CRNX icon

Crinetics Pharmaceuticals
CRNX

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$81
105% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Citizens
Citizens
Jonathan Wolleben
60% 1-yr CRNX win rate
2 Mar ‘26 3 days ago
Goldman Sachs
Goldman Sachs
Richard Law
0% 1-yr CRNX win rate
12 Jan ‘26 1 month ago
Morgan Stanley
Morgan Stanley
Jeffrey Hung
50% 1-yr CRNX win rate
6 Jan ‘26 1 month ago